Samantha Semenkow
Stock Analyst at Citigroup
(3.45)
# 922
Out of 5,141 analysts
69
Total ratings
47.37%
Success rate
6.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Initiates: Buy | $33 | $13.65 | +141.76% | 1 | Feb 17, 2026 | |
| ROIV Roivant Sciences | Maintains: Buy | $26 → $35 | $27.15 | +28.91% | 4 | Feb 10, 2026 | |
| ARGX argenx SE | Maintains: Buy | $1,124 → $1,091 | $844.41 | +29.20% | 8 | Jan 8, 2026 | |
| FOLD Amicus Therapeutics | Downgrades: Neutral | $17 → $15 | $14.34 | +1.12% | 2 | Dec 22, 2025 | |
| SYRE Spyre Therapeutics | Initiates: Buy | $64 | $43.21 | +48.11% | 1 | Dec 17, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $16 → $30 | $13.49 | +122.39% | 2 | Dec 9, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $60 → $100 | $66.55 | +50.26% | 2 | Dec 9, 2025 | |
| NKTR Nektar Therapeutics | Initiates: Buy | $102 | $73.73 | +38.34% | 1 | Nov 26, 2025 | |
| AGIO Agios Pharmaceuticals | Initiates: Buy | $38 | $29.25 | +29.91% | 1 | Nov 26, 2025 | |
| RYTM Rhythm Pharmaceuticals | Initiates: Buy | $136 | $99.78 | +36.30% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $14 | $11.23 | +24.67% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4.25 | $3.27 | +29.97% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $33 | $24.30 | +35.80% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $20.51 | -26.86% | 5 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $5 | $18.77 | -73.36% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $2.91 | +243.64% | 4 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $2.05 | +95.12% | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.49 | +243.84% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $4.01 | +274.06% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $33.50 | +138.81% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $2.97 | +371.38% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $1.79 | +737.99% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $26.60 | +87.97% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $27.59 | +102.97% | 3 | Aug 9, 2023 |
Cullinan Therapeutics
Feb 17, 2026
Initiates: Buy
Price Target: $33
Current: $13.65
Upside: +141.76%
Roivant Sciences
Feb 10, 2026
Maintains: Buy
Price Target: $26 → $35
Current: $27.15
Upside: +28.91%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $1,124 → $1,091
Current: $844.41
Upside: +29.20%
Amicus Therapeutics
Dec 22, 2025
Downgrades: Neutral
Price Target: $17 → $15
Current: $14.34
Upside: +1.12%
Spyre Therapeutics
Dec 17, 2025
Initiates: Buy
Price Target: $64
Current: $43.21
Upside: +48.11%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $16 → $30
Current: $13.49
Upside: +122.39%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $60 → $100
Current: $66.55
Upside: +50.26%
Nektar Therapeutics
Nov 26, 2025
Initiates: Buy
Price Target: $102
Current: $73.73
Upside: +38.34%
Agios Pharmaceuticals
Nov 26, 2025
Initiates: Buy
Price Target: $38
Current: $29.25
Upside: +29.91%
Rhythm Pharmaceuticals
Nov 25, 2025
Initiates: Buy
Price Target: $136
Current: $99.78
Upside: +36.30%
Nov 13, 2025
Maintains: Buy
Price Target: $28 → $14
Current: $11.23
Upside: +24.67%
Nov 11, 2025
Maintains: Neutral
Price Target: $5 → $4.25
Current: $3.27
Upside: +29.97%
Nov 7, 2025
Maintains: Buy
Price Target: $31 → $33
Current: $24.30
Upside: +35.80%
Oct 29, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $20.51
Upside: -26.86%
Oct 29, 2025
Downgrades: Sell
Price Target: $5
Current: $18.77
Upside: -73.36%
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $2.91
Upside: +243.64%
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $2.05
Upside: +95.12%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $3.49
Upside: +243.84%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $4.01
Upside: +274.06%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $33.50
Upside: +138.81%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $2.97
Upside: +371.38%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $1.79
Upside: +737.99%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $26.60
Upside: +87.97%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $27.59
Upside: +102.97%